Eurazeo, which has accompanied Elis since its initial investment in October 2007, today announces the
sale of a total of 10 million Elis shares by Eurazeo, directly and through its subsidiary Legendre Holding 27
SAS(“LH27”), and together with ECIP Elis Sarl. The disposal, representing 4.56% of
Elis’ share capital and 4.36% of Elis’ voting rights, was achieved at a price of €22.01 per share, for a total consideration of € 220 million, by way of an accelerated book building to institutional investors (the “
Placement”). The sale comprised 8,696, 854 Elis shares (i.e. 3.96% of Elis’ share capital) sold by
LH 27, 1,112,974 Elis shares (i.e. 0.51% of Elis’ share capital) sold by Eurazeo directly and 190,
172 Elis shares (i.e.0.09 of Elis’ share capital) sold by ECIP Elis Sarl.
Following completion of the Placement, LH27 hold s 6.30 % of Elis’ share capital nd 10.24 % of Elis’ voting rights.In economic terms, Eurazeo holds via LH27 an interest equivalent to 5.7% of Elis’ share capital, compared with 9.1 % prior to the Placement. Out of the three members of the Supervisory Board appointed on the proposal of Eurazeo and LH27, one will be stepping down in the coming months.
Marc Frappier, Managing Director of Eurazeo Capital, declared:
“Under the leadership of Xavier Martiré, Elis has been able to develop at an amazing pace with strong expansion outside of France. The Group has successfully accelerated its M&A strategy with recent acquisitions of Lavebras in Brazil,Indusal in Spain and the ongoing merger with Berendsen.
We strongly support the management team in this strategy which we believe will deliver material benefits for the Group and its shareholders in the future.”
This transaction generated net proceeds for Eurazeo of around €162 million.
Eurazeo realized a multiple of about 2.3 x its investment.
In accordance with market practices, a 90-day lock-up has been granted by LH 27 in respect of its remaining shareholding in Elis, subject to customary exceptions and waivers. BNP Paribas acted as Bookrunner in connection with the Placement. Rothschild acted as financial advisor to Eurazeo.
With a diversified portfolio of approximately €6 billion in assets under management, of which €1 billion is from
third parties, Eurazeo is one of the leading listed investment companies in Europe. Its purpose and mission is
to identify, accelerate and enhance the transformation potential of the companies in which it invests. The
Company covers most private equity segments through its five business divisions – Eurazeo Capital, Eurazeo Croissance, Eurazeo PME, Eurazeo Patrimoine and Eurazeo Brands. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. Eurazeo is notably a shareholder in AccorHotels, Asmodee, CIFA, CPK, Desigual, Elis, Europcar, Fintrax, Grape Hospitality, Les Petits Chaperons Rouges, Moncler, Neovia, Novacap, Sommet Education, Trader Interactive, and also SMEs such as Péters Surgical and lash Europe International, as well as start -ups such as Farfetch and Vestiaire Collective.
Eurazeo is listed on Euronext Paris.
Bloomberg: RF FP